fda compounding semaglutide crackdown october 2025 Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 while @martymakary is photographed holding bootleg # FDA to Restrict Ingredients Used
Description
That does not mean the treatment has failed for one of them

doi: 10.2337/diacare.28.5.1092 [DOI] [PubMed] [Google Scholar] 214

The region is witnessing rapid clinical adoption supported by local pharmaceutical innovation, growing endocrinology services, and increasing investment in biopharmaceutical production
However, in the obesity study, changes in BW correlated with changes in creatinine or creatinine/cystatin Cderived eGFR suggesting that cystatin Cbased eGFR is the preferred method to monitor eGFR during treatment with retatrutide

One is whether it is safe to drink on retatrutide
